The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
INSEEGO CORP | Note 3.250% 5/0 | 45782BAD6 | 19,394 | 24,456,000 | PRN | DFND | 2 | 0 | 0 | 24,456,000 | |
INSEEGO CORP | COMMON | 45782B104 | 119,655 | 11,965,504 | SH | DFND | 2 | 0 | 0 | 11,965,504 | |
INSEEGO CORP | COMMON | 45782B104 | 76,148 | 7,614,830 | SH | DFND | 1 | 0 | 0 | 7,614,830 | |
MIRATI THERAPEUTICS INC | COMMON | 60468T105 | 537,191 | 3,135,966 | SH | DFND | 1 | 0 | 0 | 3,135,966 |